Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03404206Phase 4Completed
Phase 4, randomised, double-blind trial of Aprol in postoperative pain (3 arms), sponsored by Bayer. Primary endpoint: Time to First Use of Rescue Medication at 24 hours. Started Feb 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03404206.